Jaime Vieser sold $6,022 of TCRT
director at Alaunos Therapeutics, Inc.. 3,000 shares at an average of $2.01, traded Dec 31, 2024, filed Jan 3, 2025.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -17.1%, 3m +43.9%, 6m +143.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-001257, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 31, 2024 | SOpen-market sale Common Stock | -2,182 | $2.01 | $4,386 | 26,712 | Jan 3, 2025 |
| Dec 31, 2024 | SOpen-market sale Common Stock | -818 | $2.00 | $1,636 | 25,894 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.